ストックスクリーナーアプリを入手
32.60
1.27%
0.41
アフターアワーズ：
32.73
0.13
+0.40%
前日終値:
$32.19
開ける：
$32.09
24時間の取引高:
2.54M
Relative Volume:
0.56
時価総額：
$14.00B
収益：
$2.27B
当期純損益:
$1.15B
株価収益率:
12.78
EPS:
2.55
ネットキャッシュフロー:
$2.80B
1週間 パフォーマンス:
+4.45%
1か月 パフォーマンス:
-1.27%
6か月 パフォーマンス:
+16.22%
1年 パフォーマンス:
+18.07%
1日の値動き範囲:
$32.09
$32.66
1週間の範囲:
$30.96
$32.66
52週間の値動き範囲:
$24.05
$34.20
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
RPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
32.60 | 14.00B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-03 | ダウングレード | UBS | Buy → Neutral |
| 2022-06-14 | 再開されました | UBS | Buy |
| 2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-30 | 開始されました | Tigress Financial | Buy |
| 2020-11-09 | アップグレード | UBS | Neutral → Buy |
| 2020-07-14 | 開始されました | Evercore ISI | In-line |
| 2020-07-13 | 開始されました | BofA Securities | Buy |
| 2020-07-13 | 開始されました | Citigroup | Neutral |
| 2020-07-13 | 開始されました | Cowen | Outperform |
| 2020-07-13 | 開始されました | Goldman | Neutral |
| 2020-07-13 | 開始されました | JP Morgan | Neutral |
| 2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 開始されました | SunTrust | Buy |
| 2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
Royalty Pharma plc to Announce Q1 2025 Financial Results on May 8, 2025 - Nasdaq
Legal & General Group Plc Has $67.19 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Portolan Capital Management LLC Purchases 173,721 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
APG Asset Management N.V. Boosts Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Aviva PLC Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
CenterBook Partners LP Sells 113,525 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
APG Asset Management US Inc. Buys Shares of 7,872 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Fmr LLC - MarketBeat
JPMorgan Chase & Co. Purchases 105,824 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
ADAR1 Capital Management LLC Sells 1,046,703 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Franklin Resources Inc. Sells 921,034 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma modifies acquisition agreement By Investing.com - Investing.com South Africa
Royalty Pharma modifies acquisition agreement - Investing.com
ExodusPoint Capital Management LP Invests $3.66 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Prudential PLC - MarketBeat
Headlands Technologies LLC Has $115,000 Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Geode Capital Management LLC Grows Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know - Yahoo Finance
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stock Position Cut by Rhenman & Partners Asset Management AB - MarketBeat
Integrated Quantitative Investments LLC Buys New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Enters Oversold Territory - Nasdaq
Russell Investments Group Ltd. Purchases 449,551 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Arrowstreet Capital Limited Partnership Sells 720,342 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Sei Investments Co. - MarketBeat
Royalty Pharma Appoints Vlad Coric to Board of Directors - citybiz
Royalty Pharma expands board with Biohaven CEO appointment By Investing.com - Investing.com South Africa
Royalty Pharma expands board with Biohaven CEO appointment - Investing.com Australia
Royalty Pharma Appoints Vlad Coric, M.D. to the Company's Board of Directors - The Manila Times
Biotech Leader Behind $13B Pfizer-Biohaven Deal Takes Strategic Role at Royalty Pharma - Stock Titan
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Alliancebernstein L.P. - MarketBeat
Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors - The Globe and Mail
California Public Employees Retirement System Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Allstate Corp Takes $299,000 Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Pictet Asset Management Holding SA Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Trexquant Investment LP Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Korea Investment CORP Boosts Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Norges Bank Takes Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Brandywine Global Investment Management LLC Acquires 142,176 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Elo Mutual Pension Insurance Co Buys 11,089 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
3.49%
大文字化:
|
ボリューム (24 時間):